Janet Audrain-McGovern1, Daniel Rodriguez2, Stephen Pianin3, Emily Alexander3. 1. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, 3535 Market Street, Suite 4100, Philadelphia, PA 19104, USA. Electronic address: audrain@pennmedicine.upenn.edu. 2. School of Nursing and Health Sciences, LaSalle University, 1900 West Olney Avenue Philadelphia, PA 19141, USA. 3. Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, 3535 Market Street, Suite 4100, Philadelphia, PA 19104, USA.
Abstract
OBJECTIVE: E-cigarettes are the most prevalent tobacco product used by adolescents. We sought to determine whether the presence of flavoring and/or the presence of nicotine at the first e-cigarette exposure predicted progression to current e-cigarette use (use in past 30 days) as well as escalation in use (number of days in the past 30 days) among adolescents. METHODS: Adolescents from public high schools outside of Philadelphia, PA completed in-classroom surveys at baseline (9th grade) and at 6-month intervals for the following 18 months (fall 2018, beginning of 11th grade). Adolescents who reported ever having used e-cigarettes at baseline (N = 354) comprised the analytical sample. RESULTS: We employed a two-part Latent Growth Curve Model including flavor, nicotine, and other covariates. Initial use of a flavored (vs unflavored) e-cigarette was associated with progression to current e-cigarette use (β = 0.54, z = 2.09, p = 0.04) and escalation in the number of days of e-cigarette use (β = 0.35, z = 2.58, p = 0.01) across the following 18 months. Initial use of an e-cigarette with nicotine (vs without nicotine) was associated with a greater number of days of e-cigarette use at baseline (β = 0.49, z = 2.16, p = 0.03). CONCLUSIONS: The findings underscore the risk that flavoring and nicotine pose for progression beyond initial e-cigarette use. Regulations addressing flavoring and nicotine in e-cigarettes have the potential to reduce the number of adolescents who become current as well as frequent e-cigarette users.
OBJECTIVE: E-cigarettes are the most prevalent tobacco product used by adolescents. We sought to determine whether the presence of flavoring and/or the presence of nicotine at the first e-cigarette exposure predicted progression to current e-cigarette use (use in past 30 days) as well as escalation in use (number of days in the past 30 days) among adolescents. METHODS: Adolescents from public high schools outside of Philadelphia, PA completed in-classroom surveys at baseline (9th grade) and at 6-month intervals for the following 18 months (fall 2018, beginning of 11th grade). Adolescents who reported ever having used e-cigarettes at baseline (N = 354) comprised the analytical sample. RESULTS: We employed a two-part Latent Growth Curve Model including flavor, nicotine, and other covariates. Initial use of a flavored (vs unflavored) e-cigarette was associated with progression to current e-cigarette use (β = 0.54, z = 2.09, p = 0.04) and escalation in the number of days of e-cigarette use (β = 0.35, z = 2.58, p = 0.01) across the following 18 months. Initial use of an e-cigarette with nicotine (vs without nicotine) was associated with a greater number of days of e-cigarette use at baseline (β = 0.49, z = 2.16, p = 0.03). CONCLUSIONS: The findings underscore the risk that flavoring and nicotine pose for progression beyond initial e-cigarette use. Regulations addressing flavoring and nicotine in e-cigarettes have the potential to reduce the number of adolescents who become current as well as frequent e-cigarette users.
Authors: H Isabella Lanza; Adam M Leventhal; Junhan Cho; Jessica L Braymiller; Evan A Krueger; Rob McConnell; Jessica L Barrington-Trimis Journal: Drug Alcohol Depend Date: 2020-08-28 Impact factor: 4.492
Authors: James D Sargent; Mike Stoolmiller; Hongying Dai; Jessica L Barrington-Trimis; Rob McConnell; Janet Audrain-McGovern; Adam M Leventhal Journal: Nicotine Tob Res Date: 2022-02-14 Impact factor: 5.825
Authors: Afaf F Moustafa; Daniel Rodriguez; Stephen H Pianin; Shannon M Testa; Janet E Audrain-McGovern Journal: Am J Prev Med Date: 2022-03-29 Impact factor: 6.604
Authors: Caitlin Notley; Sarah Gentry; Sharon Cox; Martin Dockrell; Michelle Havill; Angela S Attwood; Matthew Smith; Marcus R Munafò Journal: Addiction Date: 2021-11-22 Impact factor: 7.256